Literature DB >> 21216217

A rapid assay for assessment of sphingosine kinase inhibitors and substrates.

Yugesh Kharel1, Thomas P Mathews, Andrew J Kennedy, Joseph D Houck, Timothy L Macdonald, Kevin R Lynch.   

Abstract

Sphingosine kinases (SphKs) catalyze the transfer of phosphate from adenosine triphosphate (ATP) to sphingosine to generate sphingosine 1-phosphate (S1P), an important bioactive lipid molecule that mediates a diverse range of cell signaling processes. The conventional assay of SphK enzymatic activity uses [γ-(32)P]ATP and sphingosine as substrates, with the radiolabeled S1P product recovered by organic extraction, displayed by thin layer chromatography, and quantified by liquid scintillation counting. Although this assay is sensitive and accurate, it is slow and labor-intensive; thus, it precludes the simultaneous screening of more than a few inhibitor compounds. Here we describe a 96-well assay for SphKs that is rapid and reproducible. Our method, which takes advantage of the limited solubility of S1P, detects radioactive S1P adhering to the plate by scintillation proximity counting. Our procedure obviates extraction into organic solvents, postreaction transfers, and chromatography. Furthermore, our assay enables assessment of both inhibitors and substrates, and it can detect endogenous SphK activity in cell and tissue extracts. The SphK kinetic parameter, K(m), and the K(i) values of inhibitors determined with our assay and the conventional assay were indistinguishable. These results document that our assay is well-suited for the screening of chemical libraries of SphK inhibitors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216217      PMCID: PMC3049835          DOI: 10.1016/j.ab.2011.01.003

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  23 in total

1.  Determination of sphingosine kinase activity for cellular signaling studies.

Authors:  Katherine J Lee; Simon M Mwongela; Sumith Kottegoda; Laura Borland; Allison R Nelson; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2008-01-16       Impact factor: 6.986

2.  Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720.

Authors:  Yugesh Kharel; Sangderk Lee; Ashley H Snyder; Stacey L Sheasley-O'neill; Margaret A Morris; Yulius Setiady; Ran Zhu; Molly A Zigler; Tracy L Burcin; Klaus Ley; Kenneth S K Tung; Victor H Engelhard; Timothy L Macdonald; Sonia Pearson-White; Kevin R Lynch
Journal:  J Biol Chem       Date:  2005-08-10       Impact factor: 5.157

Review 3.  Sphingosine 1-phosphate: a prototype of a new class of second messengers.

Authors:  S Spiegel
Journal:  J Leukoc Biol       Date:  1999-03       Impact factor: 4.962

4.  Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.

Authors:  Thomas P Mathews; Andrew J Kennedy; Yugesh Kharel; Perry C Kennedy; Oana Nicoara; Manjula Sunkara; Andrew J Morris; Brian R Wamhoff; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide.

Authors:  L C Edsall; J R Van Brocklyn; O Cuvillier; B Kleuser; S Spiegel
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

6.  A rapid radioassay for sphingosine kinase.

Authors:  Donald A Vessey; M Kelley; Joel S Karliner
Journal:  Anal Biochem       Date:  2005-02-01       Impact factor: 3.365

7.  Development of a simple and robust assay to screen for inhibitors of sphingosine kinases.

Authors:  Hiroko Togame; Reiko Dodo; Tetsuya Inaoka; Peter Reinemer
Journal:  Assay Drug Dev Technol       Date:  2007-04       Impact factor: 1.738

8.  Discovery of novel sphingosine kinase 1 inhibitors.

Authors:  Yibin Xiang; Gary Asmussen; Michael Booker; Bradford Hirth; John L Kane; Junkai Liao; Kevin D Noson; Christopher Yee
Journal:  Bioorg Med Chem Lett       Date:  2009-09-10       Impact factor: 2.823

9.  Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.

Authors:  Lingkai Wong; Sheryl S L Tan; Yulin Lam; Alirio J Melendez
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

10.  Evaluating the utility of a bioluminescent ADP-detecting assay for lipid kinases.

Authors:  Jolanta Vidugiriene; Hicham Zegzouti; Said A Goueli
Journal:  Assay Drug Dev Technol       Date:  2009-12       Impact factor: 1.738

View more
  17 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

2.  Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.

Authors:  Elizabeth S Childress; Yugesh Kharel; Anne M Brown; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2017-04-25       Impact factor: 7.446

3.  Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.

Authors:  Andrew J Kennedy; Thomas P Mathews; Yugesh Kharel; Saundra D Field; Morgan L Moyer; James E East; Joseph D Houck; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2011-05-02       Impact factor: 7.446

Review 4.  Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.

Authors:  K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2012-07-16

5.  Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.

Authors:  Mamoru Ohtoyo; Masakazu Tamura; Nobuo Machinaga; Fumihito Muro; Ryuji Hashimoto
Journal:  Lipids       Date:  2016-09-02       Impact factor: 1.880

6.  Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors.

Authors:  Molly D Congdon; Yugesh Kharel; Anne M Brown; Stephanie N Lewis; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  ACS Med Chem Lett       Date:  2016-02-02       Impact factor: 4.345

7.  A real-time high-throughput fluorescence assay for sphingosine kinases.

Authors:  Santiago Lima; Sheldon Milstien; Sarah Spiegel
Journal:  J Lipid Res       Date:  2014-05-02       Impact factor: 5.922

8.  Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.

Authors:  Joseph D Houck; Thomas K Dawson; Andrew J Kennedy; Yugesh Kharel; Niels D Naimon; Saundra D Field; Kevin R Lynch; Timothy L Macdonald
Journal:  ACS Med Chem Lett       Date:  2016-03-01       Impact factor: 4.345

9.  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.

Authors:  Long Shuang Huang; Evgeny Berdyshev; Biji Mathew; Panfeng Fu; Irina A Gorshkova; Donghong He; Wenli Ma; Imre Noth; Shwu-Fan Ma; Srikanth Pendyala; Sekhar P Reddy; Tong Zhou; Wei Zhang; Steven A Garzon; Joe G N Garcia; Viswanathan Natarajan
Journal:  FASEB J       Date:  2013-01-11       Impact factor: 5.191

10.  Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.

Authors:  Yugesh Kharel; Mithun Raje; Ming Gao; Amanda M Gellett; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  Biochem J       Date:  2012-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.